Список литературы

1. Петеркова В.А., Безлепкина О.Б., Болотова Н.В. с соавт. Клинические рекомендации "Ожирение у детей". Проблемы Эндокринологии. 2021; 67(5): 67 - 83. https://doi.org/10.14341/probl12802.

2. Петеркова В.А., Васюкова О.В. К вопросу о новой классификации ожирения у детей и подростков. Проблемы Эндокринологии, N 2, 2015, стр. 39 - 45.

3. Locke AE., Kahali B, Berndt S I et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015, Vol. 518: 197 - 206.

4. Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249, 796 individuals reveal eighteen new loci associated with body mass index. Nat Genet 2010; 42: 937 - 48.

5. Hebebrand J, Hinney A, Knoll N, Volckmar AL, Scherag A. Molecular genetic aspects of weight regulation. Dtsch Arztebl Int 2013; 110(19): 338 - 44.

6. Петеркова В.А., Васюкова О.В. Редкие формы ожирения у детей. Лечащий врач. 2008; 3: 29 - 33.

7. , M.A.; , A.; , M.B. Global Trends in Child Obesity: Are Figures Converging? Int. J. Environ. Res. Public Health 2020, 17, 9252. https://doi.org/10.3390/ijerph17249252.

8. World Health Organization. [Электронный ресурс]//Режим доступа: http://www.who.int/mediacentre/factsheets/fs311/ru/

9. Тутельян В.А., Батурин А.К., Конь И.Я. с соавт. Распространенность ожирения и избыточной массы тела среди детского населения РФ: мультицентровое исследование. Педиатрия им. Г.Н. Сперанского. 2014; 93 (5): 28 - 31.

10. Грицинская В.Л., Новикова В.П., Хавкин А.И. К вопросу об эпидемиологии ожирения у детей и подростков (систематический обзор и мета-анализ научных публикаций за 15-летний период). Вопросы практической педиатрии. 2022; 17(2): 126 - 135. DOI: 10.20953/1817-7646-2022-2-126-135.

11. Spinelli A, Buoncristiano M, Nardone P. et al. Thinness, overweight, and obesity in 6- to 9-year-old children from 36 countries: The World Health Organization European Childhood Obesity Surveillance Initiative-COSI 2015 - 2017. Obes Rev. 2021 Nov; 22 Suppl 6: e13214. doi: 10.1111/obr.13214

12. Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 Mar 1; 102(3): 709 - 757. doi: 10.1210/jc.2016-2573.

13. Богова Е.А. Клинические, генетические и гормонально-метаболические особенности ожирения при синдроме Прадера-Вилли: автореф. дис. канд. мед. наук, М, 2014, 27 с.

14. Butler MG, Miller JL, Forster JL. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update. Curr Pediatr Rev. 2019; 15(4): 207 - 244. doi: 10.2174/1573396315666190716120925

15. Tomlinson JW. Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction. Diabetes Obes Metab. 2024 Apr; 26 Suppl 2: 13 - 24. doi: 10.1111/dom.15480.

16. Abbas A, Hammad AS, Al-Shafai M. The role of genetic and epigenetic GNAS alterations in the development of early-onset obesity. Mutat Res Rev Mutat Res. 2024 Jan - Jun; 793: 108487. doi: 10.1016/j.mrrev.2023.108487.

17. Kleinendorst L, Boon E, van Haelst MM. Obesity-Associated GNAS Mutations and the Melanocortin Pathway. N Engl J Med. 2022 Jul 21; 387(3): 285. doi: 10.1056/NEJMc2119110.

18. Holder JL Jr, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet 2000; 9: 101 - 108

19. Bonaglia MC, Ciccone R, Gimelli G, Gimelli S, Marelli S, Verheij J et al. Detailed phenotype-genotype study in five patients with chromosome 6q16 deletion: narrowing the critical region for Prader-Willi-like phenotype. Eur J Hum Genet 2008; 16: 1443 - 1449

20. Drabkin M, Birk OS, Birk R. Heterozygous versus homozygous phenotype caused by the same MC4R mutation: novel mutation affecting a large consanguineous kindred. BMC Med Genet. 2018 Aug 2; 19(1): 135. doi: 10.1186/s12881-018-0654-1. PMID: 30068297; PMCID: PMC6090656

21. Васюкова О.В. Ожирение у детей и подростков: критерии диагноза. Ожирение и метаболизм. Том 16, N 1 (2019): 70 - 73. doi. org/10.14341/omet10170

22. Петеркова В.А., Нагаева Е.В., Ширяева Т.Ю. Методические рекомендации: Оценка физического развития детей и подростков.. Москва, 2017 г., 98 стр.

23. Рекомендации по диагностике, лечению и профилактике ожирения у детей и подростков. - М.: Практика, 2015. - 136 стр.

24. L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS, Gambineri A, Garcia Rudaz C, Hoeger KM, A, Ong K, AS, Reinehr T, Santoro N, Tena-Sempere M, Tao R, Yildiz BO, Alkhayyat H, Deeb A, Joel D, Horikawa R, de Zegher F, Lee PA. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017; 88(6): 371 - 395. doi: 10.1159/000479371.

25. Петеркова В.А., Ремизов О.В. Ожирение в детском возрасте. Ожирение и метаболизм 2004; 1: 17 - 23.

26. Marcus CL, Brooks LJ, Draper KA, et al: American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep; 130(3): e714 - 55. doi: 10.1542/peds.2012-1672.

27. Александров А.А., Кисляк О.А., Леонтьева И.В. Клинические рекомендации. Диагностика, лечение и профилактика артериальной гипертензии у детей и подростков. Системные гипертензии 2020; Том 17; N 2, стр. 7 - 35; https://doi.org/10.26442/2075082X.2020.2.200126.

28. Агапитов Л.И., Александров А.А., Баранов А.А., Кисляк О.А., Леонтьева И.В., Намазова-Баранова Л.С., Плотникова И.В., Розанов В.Б. Артериальная гипертензия у детей. Клинические рекомендации МЗ РФ, 2016.

29. Molleston J. P., Schwimmer J. B., Yates K. P. et al. NASH Clinical Research Network. Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels. J Pediatr. 2014; 164: 707 - 713

30. Ивашкин В.Т., Маевская М.В., Павлов Ч.С. и др. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26(2): 24 - 42. https://doi.org/10.22416/1382-4376-2016-26-2-24-42

31. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents Summary Report, National Heart Lung and Blood Institute, NIH Publication No. 12-7486-A, 2012, 140 p.

32. Expert Panel on Integrated Pediatric Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. National Heart, Lung and Blood Institute, NIH, Bethesda, MD. Pediatrics (Supplement 5) 2011; 128: S213 - S309. Режим доступа: www.nhlbi.nih.gov/guidelines/cvd_ped/index.htm.

33. Giorgio V., Graziano F., Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013; 13: 40

34. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents/E.J. Mayer-Davis [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 7 - 19.

35. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes 2020/American Diabetes Association//Diabetes Care. 2020. Vol. 43 (Sup1): Р. S14 - S31. https://doi.org/10.2337/dc20-S002.

36. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation/World Health Organization, International Diabetes Federation. - 2006.

37. Ивашкин В.Т., Маев И.В., Баранская Е.К., Охлобыстин А.В., Шульпекова Ю.О., Трухманов А.С., Шептулин А.А., Лапина Т.Л. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению желчнокаменной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26(3): 64 - 80. https://doi.org/10.22416/1382-4376-2016-26-3-64-80

38. Сомнология и медицина сна. Национальное руководство памяти А.М. Вейна и Я.И. Левина/под ред. М.Г. Полуэктова. Москва: "Медфорум", 2016.

39. Kaditis AG, Alonso Alvarez ML, Boudewyns A, et al. Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management. Eur Respir J. 2016 Jan; 47(1): 69 - 94. doi: 10.1183/13993003.00385-2015.

40. , E., Coso, C., , M. et al. Diagnosis and Treatment of Sleep Apnea in Children: A Future Perspective Is Needed. Biomedicines 2023, 11, 1708. https://doi.org/10.3390/biomedicines11061708

41. Bhattacharjee R, Kheirandish-Gozal L, Pillar G, Gozal D. Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children. Prog Cardiovasc Dis. 2009 Mar - Apr; 51(5): 416 - 33. doi: 10.1016/j.pcad.2008.03.002.

42. Smith DF, Amin RS. OSA and Cardiovascular Risk in Pediatrics. Chest. 2019 Aug; 156(2): 402 - 413. doi: 10.1016/j.chest.2019.02.011.

43. Redline S, Storfer-Isser A, Rosen CL et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med. 2007 Aug 15; 176(4): 401 - 8. doi: 10.1164/rccm.200703-375OC.

44. Menzies B, Teng A, Burns M, Lah S. Neurocognitive outcomes of children with sleep disordered breathing: A systematic review with meta-analysis. Sleep Med Rev. 2022 Jun; 63: 101629. doi: 10.1016/j.smrv.2022.101629.

45. Ai S, Li Z, Wang S, Chen S, Chan JW, Au CT, Bao Y, Li AM, Zhang J, Chan KC, Wing YK. Blood pressure and childhood obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med Rev. 2022 Oct; 65: 101663. doi: 10.1016/j.smrv.2022.101663.

46. Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. European Thyroid Journal. 2014; 3(2): 76 - 94. doi: 10.1159/000362597

47. Arslanian SA. Clamp techniques in pediatrics: what have we learned? Horm Res. 2005; Vol. 64(3): p. 16 - 24.

48. Levy-Marchal C, Arslanian S, Cutfield W et al. ESPE-LWPES-ISPAD-APPES-APEG-SLEP-JSPE; Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010; Vol. 95(12): p. 5189 - 5198.

49. Yeckel CW, Weiss R, Dziura J et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004; Vol. 89(3): p. 1096 - 1101.

50. Васюкова О.В. Инсулин, лептин, липиды и периферические ростовые факторы при ожирении у детей: автореф. дис. канд. мед. наук, М, 2006, 24 с.

51. Takahara М, Katakami N Kaneto H, Noguchi M and Shimomura I. Distribution of the Matsuda Index in Japanese healthy subjects. J Diabetes Investig. 2013 Jul 8; 4(4): 369 - 371.. doi: 10.1111/jdi.12056

52. Kai-Yu Xiong, Hui He, Yi-Ming Zhang, Guo-Xin Ni. Analyses of body composition charts among younger and older Chinese children and adolescents aged 5 to 18 years. BMC Public Health 2012, Vol. 12: p. 835 - 844.

53. McCarthy HD, Samani-Radia D, Jebb SA, Prentice AM. Skeletal muscle mass reference curves for children and adolescents. Pediatric Obesity. 2013; Doi: 10.1111/j.2047-6310.2013.00168.x

54. Demura S, Sato S, Kitabayashi T. Percentage of total body fat as estimated by three automatic bioelectrical impedance analyzers. J. Physiol. Anthropol. Appl. Hum. Sci. 2004; Vol. 23: p. 93 - 99.

55. Malavolti M, Mussi C, Poli M. Cross-calibration of eightpolar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21 - 82 years. Ann. Hum. Biol. 2003; Vol. 30: p. 380 - 391.

56. Кедринская А.Г, Образцова Г.И, Леонова И.А. Компонентный состав у детей с избыточной массой тела и ожирением//Российский педиатрический журнал. 2018. N 2. URL: https://cyberleninka.ru/article/n/komponentnyy-sostav-tela-u-detey-s-izbytochnoy-massoy-tela-i-ozhireniem

57. The Academy of Nutrition and Dietetics. Evidence Analysis Library. Pediatric Weight Management Guidelines. 2015 http://www.adaevidencelibrary.com/topic.cfm?cat=2721.

58. Barlow SE. Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007; 120(4): S164 - S192. [PubMed: 18055651]

59. Mead E, Brown T, Rees K, Liane B Azevedo LB et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years Cochrane Database Syst Rev. 2017 Jun; 2017(6): CD012651. doi: 10.1002/14651858.CD012651

60. Павловская Е.В. Сурков А.Г., Шилина Н.М., Зубович А.И., Зейгарник М.В., Строкова Т.В. Современные подходы к диетотерапии ожирения у детей. Вопросы детской диетологии. 2016; 14(1): 41 - 46. DOI: 10.20953/1727-5784-2016-1-41-46

61. Jens-Christian Holm, Michael Gamborg, Dorthe S. Bille, Helle N. , Leigh C. Ward & Jan Faerk (2011) Chronic care treatment of obese children and adolescents, International Journal of Pediatric Obesity, 6: 3 - 4, 188 - 196, DOI: 10.3109/17477166.2011.575157

62. Александров А.А., Бубнова М.Г., Кисляк О.А. и др. Профилактика сердечно-сосудистых заболеваний в детском и подростковом возрасте. Российские рекомендации. Российский кардиологический журнал 2012; N 6 (Приложение 1): 1 - 40.

63. Всемирная организация здравоохранения. Глобальные рекомендации по физической активности для здоровья, 2010 г. Москва. 60 с. ISBN: 978 92 4 459997 6.

64. WHO guidelines on physical activity, sedentary behavior and sleep for children under 5 years of age. 2019. ISBN 978-92-4-155053-6

65. Kahle EB, Zipf WB, Lamb DR, Horswill CA, Ward KM. Association between mild, routine exercise and improved insulin dynamics and glucose control in obese adolescents. Int J Sports Med. 1996. 17: 1 - 6

66. McMurray RG, Bauman MJ, Harrell JS, Brown S, Bangdiwala SI. Effects of improvement in aerobic power on resting insulin and glucose concentrations in children. Eur J Appl Physiol. 2000, 81: 132 - 139

67. Ritenbaugh C, Teufel-Shone NI, Aickin MG, Joe JR, Poirier S, Dillingham DC, Johnson D, Henning S, Cole SM, Cockerham D. A lifestyle intervention improves plasma insulin levels among Native American high school youth. Prev Med., 2003, 36: 309 - 319

68. Кельмансон И.А. Клиническая сомнология детского возраста: учебное пособие/И.А. Кельмансон. - Санкт-Петербург: СпецЛит, 2021. - 591 с. ISBN 978-5-299-01118-0

69. Morrissey B, Taveras E, Allender S, Strugnell C. Sleep and obesity among children: A systematic review of multiple sleep dimensions. Pediatr Obes. 2020 Apr; 15(4): e12619. doi: 10.1111/ijpo.12619. Epub 2020 Feb 18. PMID: 32072752; PMCID: PMC7154640.

70. Golley RK, Maher CA, Matricciani L, Olds TS. Sleep duration or bedtime? Exploring the association between sleep timing behaviour, diet and BMI in children and adolescents. Int J Obes (Lond). 2013 Apr; 37(4): 546 - 51. doi: 10.1038/ijo.2012.212.

71. Mead E, Atkinson G, Richter B, Metzendorf MI, Baur L, Finer N, Corpeleijn E, O'Malley C, Ells LJ. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016 Nov 29; 11: CD012436.

72. Kelly AS, Auerbach P, Barrientos-Perez M, Gies I et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020 Mar 31. doi: 10.1056/NEJMoa1916038.

73. Mastrandrea LD, Witten L, Carlsson Petri KC, Hale PM, Hedman HK, Riesenberg RA. Liraglutide effects in a paediatric (7 - 11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes. 2019 May; 14(5): e12495. doi: 10.1111/ijpo.12495.

74. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005 Jun 15; 293(23): 2873 - 83.

75. Мельниченко Г.А., Петеркова В.А., Савельева Л.В., Зубкова Н.А. Оценка эффективности применения Ксеникала в комплексной терапии ожирения у подростков с метаболическим синдромом. Ожирение и метаболизм. 2011, N 4, стр. 36 - 42.

76. Freemark M. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diabetes Care 2007, 30: 395 - 402

77. Sadeghi A, Mousavi SM, Mokhtari T, Parohan M, Milajerdi A. Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Child Obes. 2020 Apr; 16(3): 174 - 191. doi: 10.1089/chi.2019.0040.]

78. Masarwa R, Brunetti VC, Aloe S, Henderson M, Platt RW, Filion KB. Efficacy and Safety of Metformin for Obesity: A Systematic Review. Pediatrics. 2021 Mar; 147(3): e20201610. doi: 10.1542/peds.2020-1610

79. Deal CL, Tony M, C, Allen DB, Tauber M, Christiansen JS. Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. J Clin Endocrinol Metab. 2013 Jun; 98(6): E1072 - 87. doi: 10.1210/jc.2012-3888. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

80. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008 Jun; 152(6): 817 - 22. doi: 10.1016/j.jpeds.2008.01.018

81. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023 Sep 18; 108(10): 2447 - 2469. doi: 10.1210/clinem/dgad463

82. Robert H. Lustig, Pamela S. Hinds, Karen Ringwald-Smith, Robbin K. Christensen, Sue C. Kaste, Randi E. Schreiber, Shesh N. Rai, Shelly Y. Lensing, Shengjie Wu, Xiaoping Xiong, Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial, The Journal of Clinical Endocrinology & Metabolism, Volume 88, Issue 6, 1 June 2003, Pages 2586 - 2592, https://doi.org/10.1210/jc.2002-030003

83. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr., 1999, 135: 162 - 168

84. Passone CGB, Franco RR, Ito SS, Trindade E, Polak M, Damiani D, Bernardo WM. Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr Open. 2020 Apr 29; 4(1): e000630. doi: 10.1136/bmjpo-2019-000630. PMID: 32411831; PMCID: PMC7213882

85. Scheermeyer E, Harris M, Hughes I, Crock PA, Ambler G, Verge CF, Bergman P, Werther G, Craig ME, Choong CS, Davies PSW; PWS and OZGROW collaboration. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens. Growth Horm IGF Res. 2017 Jun; 34: 1 - 7. doi: 10.1016/j.ghir.2017.03.001.

86. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med., 1999, 341: 879 - 884

87. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest., 2002, 110: 1093 - 1103

88. P, K, Wiegand S, Blankenstein O, Gottesdiener K, Martini LL, Mai K, Blume-Peytavi U, A, Krude H. Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist. N Engl J Med. 2016 Jul 21; 375(3): 240 - 6. doi: 10.1056/NEJMoa1512693.

89. IPEG guidelines for surgical treatment of extremely obese adolescents. J Laparoendosc Adv Surg Tech A. 2009 Feb; 19(1): xiv - xvi. doi: 10.1089/lap.2009.9997.

90. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts. 2008; 1(1): 52 - 9. doi: 10.1159/000113937. Epub 2008 Feb 8.

91. Pratt JSA, Browne A, Browne NT, Bruzoni M, Cohen M, Desai A, Inge T, Linden BC, Mattar SG, Michalsky M, Podkameni D, Reichard KW, Stanford FC, Zeller MH, Zitsman J. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018 Jul; 14(7): 882 - 901. doi: 10.1016/j.soard.2018.03.019

92. Black JA, White B, Viner RM, Simmons RK. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. ObesRev. 2013 Aug; 14(8): 634 - 44. doi: 10.1111/obr.12037. Epub 2013 Apr 11.

93. Inge TH, Zeller MH, Jenkins TM, Helmrath M, Brandt ML, Michalsky MP, Harmon CM, Courcoulas A, Horlick M, Xanthakos SA, Dolan L, Mitsnefes M, Barnett SJ, Buncher R. Teen-LABS Consortium. Perioperative outcomes of adolescents undergoing bariatric surgery: the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study. JAMA Pediatr. 2014 Jan; 168(1): 47 - 53. doi: 10.1001/jamapediatrics.2013.4296.

94. G, Gronowitz E, Flodmark CE, Dahlgren J, Ekbom K, S, Marcus C, Olbers T. Laparoscopic Roux-en-Y gastric bypass in adolescents with morbid obesity--surgical aspects and clinical outcome. SeminPediatr Surg. 2014 Feb; 23(1): 11 - 6. doi: 10.1053/j.sempedsurg.2013.10.015.

95. Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, Harmon CM, Zeller MH, Chen MK, Xanthakos SA, Horlick M, Buncher CR; Teen-LABS Consortium. Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med. 2016 Jan 14; 374(2): 113 - 23. doi: 10.1056/NEJMoa1506699.

96. Olbers T, Beamish AJ, Gronowitz E, Flodmark CE, Dahlgren J, Bruze G, Ekbom K, Friberg P, G, K, Karlsson J, S, Neovius M, Peltonen M, Marcus C. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 2017 Mar; 5(3): 174 - 183. doi: 10.1016/S2213-8587(16)30424-7.

97. Paulus GF, de Vaan LE, Verdam FJ, Bouvy ND, Ambergen TA, van Heurn LW. Bariatric surgery in morbidly obese adolescents: a systematic review and meta-analysis. Obes Surg. 2015 May; 25(5): 860 - 78. doi: 10.1007/s11695-015-1581-2.

98. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 2014; 24: 437 - 55.

99. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022 Dec; 18(12): 1345 - 1356. doi: 10.1016/j.soard.2022.08.013.

100. Till H, Mann O, Singer G, S. Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents. Children (Basel). 2021 May 9; 8(5): 372. doi: 10.3390/children8050372

101. Beamish AJ, Ryan Harper E, K, Janson A, Olbers T. Long-term Outcomes Following Adolescent Metabolic and Bariatric Surgery. J Clin Endocrinol Metab. 2023 Aug 18; 108(9): 2184 - 2192. doi: 10.1210/clinem/dgad155.

102. Scheimann AO, Butler MG, Gourash L, Cuffari C, Klish W. Critical analysis of bariatric procedures in Prader-Willi syndrome. J Pediatr Gastroenterol Nutr 2008; 46(1): 80 - 3.

103. Alqahtani AR, Elahmedi MO, Al Qahtani AR, Lee J, Butler MG. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study. Surg Obes Relat Dis 2016; 12(1): 100 - 10